THRA and colorectal carcinoma: Moreover, the expression of the THRA gene is upregulated in CRC consensus molecular subtypes (CMS) compared to the normal colon, with significantly higher overexpression in CMS2 [15], which is characterized by high Wnt and Myc signaling activation [23].